ArticlePLoS neglected tropical diseases2025
Aspartic protease 2 from Trichinella spiralis excretion/secretion products hydrolyzes tight junctions of intestinal epithelial cells.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trichinella spiralis galectin disrupts gut epithelial integrity and mediates larval invasion via acting MUC13- ROCK2/MAPK pathway.PLoS neglected tropical diseases · 2026Article
- Molecular characterization of a novel Trichinella spiralis aspartyl protease and its role in the larval invasion of host intestinal epithelial cells.Parasite (Paris, France) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Trichinella spiralis is a globally distributed foodborne parasitic nematode causing zoonotic infections. The invasion and subsequent development of intestinal infective larvae within the intestinal mucosa are critical steps in T. spiralis infection of the host. Previous studies have demonstrated that aspartic protease 2 from Trichinella spiralis excretion/secretion products (TsASP2) plays a role in facilitating the invasion of host intestinal epithelial cells by the larvae; however, the underlying mechanism remains unclear. Studies have suggested that dysfunction of the intestinal barrier creates a more favorable environment for intestinal helminths to invade intestinal epithelial cells. Here, the role of recombinant TsASP2 (rTsASP2) in disrupting the intestinal barrier by hydrolyzing tight junctions (TJs) was analyzed using both in vitro and in vivo experiments. A Lactococcus lactis- based heterologous protein delivery system was constructed to deliver TsASP2 to intestinal mucosa. The expression and mucosal colonization of rTsASP2 in L. lactis, the integrity of the intestinal epithelium, and the degradation of TJ proteins and hydrolysis sites of rTsASP2 were confirmed with Western blot, immunofluorescence, transepithelial electrical resistance (TEER) detection, paracellular permeability to FITC-dextran, transmission electron microscopy (TEM), dextran sulfate sodium (DSS)-induced colitis model, and High-Performance Liquid Chromatography Coupled to Time-of-Flight Mass Spectrometry (HPLC-TOF/MS). Results revealed TsASP2 delivery system using L. lactis was successfully construction and capable of colonizing the gut and delivering rTsASP2 to the intestinal mucosa. The rTsASP2 could directly degrade the TJ proteins Occludin and Claudin-1, thereby increasing paracellular permeability in the intestinal barrier and exacerbating DSS- induced colitis in mice. HPLC-TOF/MS analysis of the bands generated by rTsASP2- mediated hydrolysis of TJ protein specifically identified the cleavage sites as K-S, R-A, R-T, R-E and R-L. These results elucidated the mechanism by which TsASP2 facilitates T. spiralis invasion through the hydrolysis of tight junction proteins, providing critical experimental evidence for understanding host-parasite interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.